| D007956 |
Leukocidins |
Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms. |
Leucocidin,Leukocidin,Leukocidin Proteins,Proteins, Leukocidin |
|
| D008826 |
Microbial Sensitivity Tests |
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). |
Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity |
|
| D005098 |
Exotoxins |
Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. |
Exotoxin |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D001427 |
Bacterial Toxins |
Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. |
Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial |
|
| D013211 |
Staphylococcus aureus |
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications. |
|
|
| D016106 |
Methicillin Resistance |
Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative. |
Methicillin-Resistant,Methicillin Resistant,Resistance, Methicillin |
|
| D016521 |
Electrophoresis, Gel, Pulsed-Field |
Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length. |
Electrophoresis, Gel, Pulsed-Field Gradient,Gel Electrophoresis, Pulsed-Field,Contour-Clamped Homogeneous-Field Gel Electrophoresis,Electrophoresis, Gel, Pulsed Field,Electrophoresis, Pulsed Field Gel,Field Inversion Gel Electrophoresis,Orthogonal Field Alternation Gel Electrophoresis,Orthogonal-Field Alternation-Gel Electrophoresis,Pulsed Field Gradient Gel Electrophoresis,Pulsed-Field Gel Electrophoresis,Pulsed-Field Gradient Gel Electrophoresis,Alternation-Gel Electrophoresis, Orthogonal-Field,Contour Clamped Homogeneous Field Gel Electrophoresis,Electrophoresis, Orthogonal-Field Alternation-Gel,Electrophoresis, Pulsed-Field Gel,Gel Electrophoresis, Pulsed Field,Pulsed Field Gel Electrophoresis |
|
| D017714 |
Community-Acquired Infections |
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. |
Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired |
|
| D021821 |
Communicable Diseases, Emerging |
Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode. |
Infectious Diseases, Emerging,Communicable Diseases, Re-Emerging,Communicable Diseases, Reemerging,Infectious Diseases, Re-Emerging,Infectious Diseases, Reemerging,Communicable Disease, Emerging,Communicable Disease, Re-Emerging,Communicable Disease, Reemerging,Communicable Diseases, Re Emerging,Disease, Emerging Communicable,Disease, Emerging Infectious,Disease, Re-Emerging Communicable,Disease, Re-Emerging Infectious,Disease, Reemerging Communicable,Disease, Reemerging Infectious,Diseases, Emerging Communicable,Diseases, Emerging Infectious,Diseases, Re-Emerging Communicable,Diseases, Re-Emerging Infectious,Diseases, Reemerging Communicable,Diseases, Reemerging Infectious,Emerging Communicable Disease,Emerging Communicable Diseases,Emerging Infectious Disease,Emerging Infectious Diseases,Infectious Disease, Emerging,Infectious Disease, Re-Emerging,Infectious Disease, Reemerging,Infectious Diseases, Re Emerging,Re-Emerging Communicable Disease,Re-Emerging Communicable Diseases,Re-Emerging Infectious Disease,Re-Emerging Infectious Diseases,Reemerging Communicable Disease,Reemerging Communicable Diseases,Reemerging Infectious Disease,Reemerging Infectious Diseases |
|
-transparent.png){kind=logo}
